About D. Keyser
D. Keyser is a director at Lantern Pharma.
Form D filings name D. Keyser as a chief executive officer and director at Renibus Therapeutics.
D. Keyser reports to the SEC as a director or officer of 3 public companies, including ZS Pharma (ZSPH) and Encysive Pharmaceuticals (ENCY).
D. Keyser first appears on SEC filings in 2007.
Experience
This experience comes from SEC filings. The years are when the filings name D. Keyser in the role, so the role may have started earlier or lasted longer.
LI
Lantern Pharma Inc.
Director
2020 – 2026 · Public company (LTRN)
ZI
ZS Pharma, Inc.
Chief Operating Officer and director
2014 – 2015 · Public company (ZSPH)
EI
Encysive Pharmaceuticals Inc.
V.P., Regulatory Affairs
2007 – 2008 · Public company (ENCY)
Key Colleagues at Startups
The people D. Keyser works with at each company, as listed on that company's latest Form D.
Renibus Therapeutics, Inc. · Form D/A, Jul 17, 2025
JD
Jamie Donadio
Executive officer
BS
Bhupinder Singh
Executive officer and director
CG
Carlos Guillem
Director
HR
Henrik Rasmussen
Director